CD274 and neoplasm: Such studies have already been performed with other antibodies in the context of immunohistochemical detection of PD-L1 in tumor tissue and lymph nodes, showing that different antibodies indeed have different propensities to bind PD-L1 on tumor cells versus immune cells, and sometimes even discriminate between lymphocyte-like cells versus DCs [24].